Purchase by Jason Haas (Chief Financial Officer)
1,000 shares · @ $20.00 · $20,000
Odyssey Therapeutics, Inc. Common Stock · Now $16.96
-1.6% in 3d after detection
Post-detection moves
1h
—
1d
+0.2%
3d
-1.6%
7d
-0.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS